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SUM M ARY
Monoclonal antibody (MAb) RC38 recognizes a human renal antigen of 160 kD recently identified as human aminopeptidase A 
(APA; EC 3.4.11.7). This ectoenzyme is able to hydrolyse selectively N-terminal glutamyl and aspartyl residues from oligopeptides. By 
enzyme histochemistry, APA activity has also been localized in the microvessels of all organs in animals and man. The purpose of this 
study was to investigate the distribution of human APA as recognized by MAb RC38 in the microvasculature of normal human tissues 
and pathological conditions associated with neovascularization. Unexpectedly, in normal tissues vascular staining with MAb RC38 was 
generally weak and often absent, while in tumours, granulation tissue, and chronic synovitis, marked microvascular staining was 
demonstrated. By immuno-electron microscopy, the antigen was found on the cell membrane of activated pericytcs and their processes 
in the tumour vasculature. RC38 expression could not be detected on cultured human endothelial cells or pericytes. These observations 
suggest that pericyte expression of a subtype of APA (as recognized by MAb RC38) is markedly enhanced in the vasculature of tumours 
and wound healing tissue as compared with normal resting tissues. This provides further evidence of the altered state of pericytes in these 
conditions. Pericyte APA may be involved in the metabolism of biologically active oligopeptides during neovascularization, supporting 
a regulatory role of pericytes in this process. In addition, MAb RC38 may be useful as a marker of pericyte activation in tissue sections.
k e y  WORDS—aminopeptidase A; angiogenesis; pericytes; MAb RC38; tumours; wound healing
INTRODUCTION
The role o f pericytes in the process of angiogenesis 
remains controversial.1"*3 Based on in vitro studies, some 
authors attribute to these cells an inhibiting influence on 
the proliferation o f endothelial cells in the end stage 
of the angiogenic response. J*4’5 On the basis o f morpho­
logical studies,6-10 others have suggested that pericytes 
already play an active role in the initial stages o f  
neovascularization.
Early ultrastructural reports on angiogenesis in situ 
demonstrated pericytes with plump cell bodies and 
an increased number of cell organelles near angio­
genic stimuli, signs that were attributed to cellular 
‘activation’. 11-14 In recent reports, we have demon­
strated that such activated pericytes occur in increased 
numbers in microvessels in tumours and granulation 
tissue.7’8’15 Furthermore, these cells were found to have 
enhanced expression of a chondroitin sulphate proteo­
glycan (HMW -MAA) that was previously implicated in 
the metastatic potential and migration of melanoma 
cells,7»15 From these studies we concluded that activated 
pericytes are already present at the onset of angiogenesis 
and that their altered phenotype may enable them to 
migrate or perform other specialized functions.
In the present study we have focused on the expres­
sion in pericytes of the ectoenzyme aminopeptidase A  
(glutamyl aminopeptidase, APA; EC 3.4.11,7) as recog­
nized by the monoclonal antibody (MAb) RC38.16 APA  
is able to hydrolyse selectively N-terminal glutamyl and
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aspartyl residues from oligopeptides. 17-20 Angiotensin
II, a potent constrictor o f blood vessels, is an important 
substrate o f the enzyme. APA activity has been demon­
strated by enzyme histochemistry in epithelial brush 
borders in the kidney and small intestine and in the 
microvasculature of all organs in the rat, guinea pig, and 
man, 17*21 The latter was interpreted as endothelial reac­
tivity. However, a recent immunohistochemical study of 
APA in the rat brain suggested that vascular staining is 
solely based on expression by pericytes.20
The RC38 antibody was previously described as rec­
ognizing a renal antigen. 16 Its distribution in the kidney 
and other characteristics suggested similarity to MAb 
S4,22 which recognizes a renal 160 kD  glycoprotein that 
was recently identified as human A P A .23 In this report 
we demonstrate by immunoprécipitation studies that 
MAb RC38 also recognizes human APA and we report 
on the tissue distribution of human APA as recognized 
by MAb RC38 in normal tissues and in pathological 
conditions associated with angiogenesis. We found 
marked staining of microvessels in tumours and granu­
lation tissue, compared with weak or absent staining in 
vessels o f normal organs. This appeared to be based on 
staining o f activated pericytes, as evidenced by immuno- 
electron microscopic studies. We conclude that activated 
pericytes express a form o f APA that may be involved in 
the metabolism of biologically active peptides during 
angiogenesis.
MATERIALS AND M ETHODS
Tissue samples
Samples from normal and pathological human tissues 
were obtained from fresh surgical specimens and from
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Table I—Tissues used for immun oh is to chemistry
Normal tissues Number Pathological tissues Number
Skin 6 Vasoformative tumours
Oesophagus 1 Haemangioma 2
Jejunum 1 Angiosarcoma 1
Colon 4 Pyogenic granuloma 2
Pancreas 4
Liver 2 Other tumours
Spleen 5 Breast neoplasms 16
Lymph node 4 Colonic neoplasms 12
Tonsil 2 Neuroblastoma 1
Thymus 4 Sarcoma 4
Thyroid 2 Melanoma 4
Lung 1 Meningioma 2
Kidney 4 Glioblastoma multiforme 8
Ovary I Haemangiopericytoma 1
Testis 1
Cerebral cortex 5 Wound healing
Cerebellum 2 Decubitus lesion 6
Skeletal muscle 2 Burn wound 4
Breast 3 Chronic synovitis 4
Placenta 4
patients who were autopsied within 8 h after death* 
Included in the study were normal tissues, neoplasms, 
granulation tissues, and vasoformative,tumours (Table 
I). A ll tissues were snap-frozen and stored at — 70°C. 
For immuno-electron microscopy, selected tissue 
sam ples were promptly fixed in 2 per cent paraformal­
dehyde in Sorensen phosphate buffer after surgical 
removal.
Cultured cells
Microvascular endothelial cells were isolated from 
hum an foreskin and cultured in Dulbecco’s minimal 
essential medium supplemented with 40 per cent normal 
hum an serum.24 Human umbilical vein endothelium, 
fibroblasts, human brain pericytes, and a renal carci­
nom a cell line (SK-RC-1) were isolated and grown in 
culture as described elsewhere.7,24 Different passages 
were used for immunoperoxidase staining of cytospin 
preparations.
Imm unoper oxidase s tain ing
Air-dried frozen tissue sections and culture coverslips 
were fixed with acetone for 10 min and stained by a 
sensitive indirect immunoperoxidase procedure, using 
M A b  RC38 and anti-endothelial MAb PAL-E25 at 
appropriate dilutions and goat anti-mouse IgG conju­
gated to horseradish peroxidase (HRP, TAGO Inc., 
Burlingame, CA, U .S A .) as secondary antibody. 3,3- 
Diaminobenzidine (DAB) containing 1 m M  imidazole 
and 0*01 per cent H20 2 was used as substrate for 10 
m in .7 In a double staining experiment, sections o f a lung 
carcinoma metastasis in the brain DAB stained with 
R C 38 (brown precipitate) were washed three times with 
0*1 M glycine-HCl, pH 3*0 to remove bound primary 
antibody and conjugate and then stained with anti-
endothelial MAb PAL-E, using 4-chloro-l-naphthol as 
substrate (blue-grey precipitate). Sections were counter­
stained with haematoxylin. The sections were examined 
by two independent observers (ROS and DJR). In the 
occasional case o f  discrepancy, the slides were jointly 
re-evaluated until consensus was reached. Staining 
intensity was graded as follows: 110 staining ( - ) ,  weak 
staining (+ / - ) ,  moderate staining (+), or intense 
staining (+ + ) .
Immuno-electron microscopy
A  pre-embedding immunoperoxidase technique 
described in detail elsewhere7»15 was used to demonstrate 
the ultrastructural distribution o f the staining with MAb 
RC38. Briefly, surgical material with a maximum size of 
4 x 6 x 2  mm was promptly fixed for 4 h in 2 per cent 
paraformaldehyde in Sorensen buffer (pH 7*4). After 
washing in 2*3 m sucrose solution, the tissue was im­
mediately frozen in liquid nitrogen and stored at 
— 196°C. On a cryomicrotome (Micron, Heidelberg, 
Germany), 30 /¿m sections were cut at -  20°C. These 
sections were incubated overnight with the first antibody 
at 4°C. After washing, the sections were incubated 
at room temperature for 1*5 h with a peroxidase- 
conjugated rabbit anti-mouse and/or swine anti-rabbit 
antibody (Dakopatts/ITK) at appropriate dilutions in 
PBG. Control sections were incubated with the second 
antibodies alone. After extensive washing, the sections 
were incubated in a 5 mg/ml DAB solution in PBS 
containing 3 mg/ml ammonium-nickel-sulphate- 
hexahydrate (FLU K A  09885, Buchs, Switzerland). The 
sections were then developed for 8-10  min in the same 
solution containing 0*01 per cent H20 2 (30 per cent). 
The reaction was terminated by rinsing with tap water. 
The sections were post-fixed in 1 per cent osmium 
tetroxide for 5 min at room temperature, dehydrated, 
and embedded in Epon 812. Ultrathin sections were 
contrasted for 1 min with 3 per cent uranyl acetate and 
examined and photographed with a JEOL 1200 EX/II 
electron microscope (Tokyo, Japan) at 40 kV.
Characterization o f the RC38 antigen
Sequential immunoprecipitation with MAb RC38 and 
MAb S4, an antibody known to recognize human 
aminopeptidase A ,22)23 was performed as follows: SK- 
RC-1 cells were metabolically labelled overnight with 
[3H]glucosamine, washed, and lysed as described in ref. 
23. Cell lysates were incubated with RC38 or S4 for 2 h 
and incubated with Sepharose-CL-4B protein A beads. 
After 1 h, the beads were washed and the immuno- 
precipitates were separated by polyacrylamide gel elec­
trophoresis (PAAGE). Autoradiography was performed 
using Kodak diagnostic film. Films were developed in a 
Kodak RP X-O M AT processor (Eastman Kodak, 
Rochester, N Y , U .S.A .).
Lysates depleted by RC38 or S4 were treated with the 
same M Ab as described above, to ensure complete 
depletion o f the lysate o f their respective antigens. These 
immunoprecipitates were also investigated by PAAGE. 
Thereafter, RC38-treated lysates were incubated with
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MAb S4 and vice versa. The remainder o f the procedure 
was as described above.
RESULTS
Tissue distribution by MAb RC38
The distribution of the antigen recognized by MAb 
RC38 was studied using immunohistochemistry on 
frozen tissue sections. Variable but often intense staining 
of capillaries and small venules with MAb RC38 was 
observed in the stroma o f most neoplasms (Figs IE and 
IF). In benign lesions of the breast, microvascular RC38 
staining was strong in proliferative mastopathy but 
weaker in other lesions (Table II). In vasoformative 
tumours, profound staining of stromal capillaries was 
seen. The multilayered cell layer lining the vascular 
spaces of a pyogenic granuloma and some spindle cell 
areas in an angiosarcoma were also positive (results not 
shown). In chronically inflamed synovia and in the 
superficial parts of granulation tissue in decubitus 
lesions, vascular staining with MAb RC38 was also 
observed (Figs 1A and IB). In the deeper fibrous areas 
of granulation tissues and in adjacent normal skin, 
RC38 staining was focally weak or absent.
Capillaries and small venules in normal tissues 
showed only focal and weak positivity in pancreas, 
lymphoid tissues, and intestinal mucosa (Figs 1C and 
ID). In the other normal tissues, no microvascular 
staining with MAb RC38 was observed. Smooth muscle 
cells in the walls of arterioles, arteriess and larger veins 
were negative in all tissues (Fig. ID).
The epithelium of the proximal tubule and glomerulus 
of the normal kidney showed marked staining, while 
reactivity was also found in the luminal epithelial brush 
border of the small intestine and colon, the placental 
trophoblast, the red pulp o f spleen, and periportal 
sinusoidal liver cells, a pattern suggestive o f staining o f  
Kupffer or I to cells (results not shown).
In the RC38-stained microvessels in tumours and 
granulation tissue, unstained luminal cells were oc­
casionally seen, suggesting that non-endothelial cells 
were recognized by the antibody (Figs IB and IF). 
To investigate which cells were recognized, a double- 
staining experiment was performed in sections o f a lung 
carcinoma metastasis to the brain, with MAb RC38 and 
with MAb PAL-E, a general endothelial marker. The 
complementary staining pattern for PAL-E (luminal 
cells) and RC38 (abluminal cells) suggested staining of 
endothelial cells and pericytes, respectively (results not 
*
shown).
Immuno-electron microscopy
The distribution of the RC38 antigen at the ultrastruc- 
tural level was studied using pre-embedding immuno-
peroxidase staining of thick cryomicrotome sections of a 
glioblastoma, a neuroblastoma, three colonic carcino­
mas, normal kidney, and prostate. In all tumours 
marked staining o f pericyte cell membranes and pericyte 
processes was observed (Fig. 2). In the normal kidney, 
staining with RC38 was confined to the brush border of 
the epithelium of renal proximal tubules and glomeruli. 
Pericytes and their processes, observed in the walls of 
capillaries in normal kidney and prostate, did not stain 
(results not shown). In none o f the examined tissues was 
endothelial staining observed.
Cultured cells
There was no staining of endothelial cells, fibroblasts, 
keratinocytes, or melanocytes in primary human fore­
skin cultures, or o f cultured human brain pericytes and 
endothelial ceils from umbilical vein. Weak staining was 
seen in SK-RC-1 renal carcinoma cells (results not 
shown).
Biochemical characterization o f  the RC38 antigen
The RC38 antigen showed a normal tissue distri­
bution very similar to that o f the antigen recognized by 
MAb S4. 16 We therefore investigated whether the RC38 
antigen might be identical to the S4 antigen. Radio- 
immunoprécipitation o f SK-RC-1 cells with RC38 
revealed the specific precipitation o f a glycoprotein with 
a molecular weight o f 160kD  (gpl60), identical to the 
antigen recognized by MAb S4. However, where S4 
precipitates revealed multiple gpl60 species, probably 
due to different glycosylation patterns,22 the RC38 pre­
cipitates showed only one discrete gpl60. The molecule 
recognized by MAb S4 has recently been identified as 
aminopeptidase A .23 Sequential immunoprécipitation of 
gp 160-positive cell lysates revealed that RC38 was 
unable to deplete any gpl60 from S4-depleted material. 
In the reverse experiment, S4 precipitated gpl60 
material, with a clear defect o f the RC38-related 
gpl60, indicating that RC38 recognizes a subset of the 
S4-related gpl60.
DISCUSSION
Pericytes are found in varying numbers in all organs,26 
but their function is poorly understood. Like vascular 
smooth muscle cells, they contain all the necessary 
elements for contraction, suggesting a role in the 
regulation o f blood flow in the microvasculature.2’26 
Recently, these cells have received much attention as 
to their presumed role in the process of angiogenesis. 
Early reports suggested a function in mechanical sup­
port and basement membrane formation in newly
Fig. 1—Immunoperoxidase staining with anti-APA MAb R.C38 (B, D, and F, right panels) and with anti-endothelial MAb PAL-E (A, C, and E, 
left panels) of adjacent frozen tissue sections of surgically removed granulation tissue (A and B, upper panels) and serial sections of normal colon 
(C and D, middle panels) and colonic carcinoma (E and F, lower panels). MAb RC38 stains microvessels in the granulation tissue (B) and tumour 
stroma (F); note the unstained endothelial nuclei along the lumina of vessels (indicated by arrows). In normal colonic mucosa and submucosa, 
microvessels are staining with MAb PAL-E (C, indicated by arrows), but not with MAb RC38 (D)
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shows only weak or absent microvascular staining in 
normal tissues. This suggests, like our biochemical find­
ings, that RC38 recognizes a separate species o f APA  
(probably underglycosylated) that has enhanced ex­
pression in activated pericytes and therefore may have 
a special function in these cells, possibly related to 
angiogenesis.
A PA  is not the first ectoenzyme demonstrated on 
pericytes. Previously, gamma-glutamyl transpeptidase 
and aminopeptidase M were localized in brain peri­
cytes.30,31 As these enzymes may regulate or neutralize 
neurotransmitters and other active oligopeptides, their 
expression by cerebral pericytes was considered as a sign 
of involvement of these cells in the blood-brain barrier 
function of brain vessels.30’31
Aminopeptidase A has not previously been implicated 
in pericyte activation or angiogenesis. The enzyme acts 
on peptides with an N-terminal acidic amino acid 
and thus selectively hydrolyses glutamyl and aspartyl 
residues.20’23,32 An important substrate of APA is 
angiotensin II, which is metabolized into angiotensin III. 
These are both potent vasoactive peptidases with sys­
temic and local effects on vascular tone.20 Interestingly, 
angiotensin II can also stimulate angiogenesis in the 
rabbit cornea and chorioallantoic membrane (CAM) 
angiogenesis assays.32' 35 Recently, a novel receptor for 
angiotensin II was demonstrated in the CAM34 and 
this receptor is probably located on the pericytes.36 
W e suggest that APA is involved in the degradation 
by pericytes of angiotensin II and other important 
regulatory oligopeptides23 involved in tissue regenera­
tion and angiogenesis. The numerous activated pericytes 
in microvessels in angiogenesis7’8 are strategically local­
ized to act, by their expression of APA, as regulators o f  
the activity of such factors.
Vascular smooth muscle cells were not stained with 
M A b RC38. This observation is interesting, as pericytes 
and smooth muscle cells have many common features 
and are regarded as closely related cell types.4’26 
Membrane determinants distinguishing these cell types 
could be useful in histopathology, or help to identify 
functional differences.2’3*31
In conclusion, the special form of APA that is recog­
nized by MAb RC38 in activated pericytes may provide 
these cells with a regulatory ectoenzyme involved in the 
process of angiogenesis. Our findings give further evi­
dence for an altered phenotype of activated pericytes 
and identify MAb RC38 as another marker for these 
cells in conditions with neovascularization.
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